Healthcare Realty Trust (NYSE:HR) Receives Sell (D+) Rating from Weiss Ratings

Healthcare Realty Trust (NYSE:HR - Get Free Report)'s stock had its "sell (d+)" rating reiterated by research analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

Other equities research analysts also recently issued research reports about the company. Raymond James Financial downgraded Healthcare Realty Trust from a "market perform" rating to an "underperform" rating in a report on Monday, September 15th. JPMorgan Chase & Co. cut their price target on Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating on the stock in a report on Thursday, June 26th. Royal Bank Of Canada assumed coverage on Healthcare Realty Trust in a report on Wednesday. They set a "sector perform" rating and a $19.00 price target on the stock. BTIG Research restated a "buy" rating and set a $20.00 price target on shares of Healthcare Realty Trust in a report on Monday, September 29th. Finally, Scotiabank upgraded Healthcare Realty Trust from a "sector perform" rating to a "sector outperform" rating and upped their price target for the stock from $18.00 to $20.00 in a report on Friday, September 5th. Three analysts have rated the stock with a Buy rating, four have given a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $18.50.

Healthcare Realty Trust Trading Down 1.4%

HR stock opened at $17.71 on Wednesday. The company has a market capitalization of $6.23 billion, a PE ratio of -15.40 and a beta of 0.96. Healthcare Realty Trust has a 12-month low of $14.09 and a 12-month high of $18.82. The business's fifty day moving average price is $17.41 and its 200 day moving average price is $16.16.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.01. The firm had revenue of $287.07 million for the quarter, compared to the consensus estimate of $290.83 million. Healthcare Realty Trust had a negative return on equity of 7.70% and a negative net margin of 32.95%.During the same quarter in the previous year, the business earned $0.38 EPS. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. Research analysts predict that Healthcare Realty Trust will post 1.59 EPS for the current fiscal year.

Insider Activity

In other news, EVP Julie F. Wilson sold 15,000 shares of the company's stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $18.00, for a total transaction of $270,000.00. Following the completion of the transaction, the executive vice president directly owned 113,419 shares of the company's stock, valued at approximately $2,041,542. This represents a 11.68% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Thomas N. Bohjalian acquired 10,000 shares of the stock in a transaction dated Wednesday, August 13th. The shares were acquired at an average cost of $16.46 per share, with a total value of $164,600.00. Following the completion of the transaction, the director owned 75,520 shares in the company, valued at approximately $1,243,059.20. This represents a 15.26% increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 0.37% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the business. Rush Island Management LP boosted its position in shares of Healthcare Realty Trust by 13.8% in the 2nd quarter. Rush Island Management LP now owns 14,260,152 shares of the real estate investment trust's stock valued at $226,166,000 after purchasing an additional 1,728,491 shares during the period. Massachusetts Financial Services Co. MA boosted its position in shares of Healthcare Realty Trust by 15.0% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 6,859,453 shares of the real estate investment trust's stock valued at $108,791,000 after purchasing an additional 893,938 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Healthcare Realty Trust by 11.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 6,794,815 shares of the real estate investment trust's stock valued at $107,766,000 after purchasing an additional 683,211 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of Healthcare Realty Trust by 1.7% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 5,562,311 shares of the real estate investment trust's stock valued at $88,218,000 after purchasing an additional 92,112 shares during the period. Finally, Thrivent Financial for Lutherans boosted its position in shares of Healthcare Realty Trust by 9.0% in the 2nd quarter. Thrivent Financial for Lutherans now owns 4,613,166 shares of the real estate investment trust's stock valued at $73,164,000 after purchasing an additional 380,379 shares during the period.

About Healthcare Realty Trust

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.